Indapamide

吲达帕胺

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameIndapamide
Drug Alias Name磺胺酰胺吲哚Indapamida吲哒帕胺IndapamidumFludex +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSymporters inhibitors
TargetsSymporters
Therapy Area/IndicationsEdemaEssential HypertensionHypertension
Global Approved IndicationsEssential HypertensionHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOril Industrie SasTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsEdemaEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC03BA11
Related LinksWikipediaDrugBankKEGG